In conclusion, our study revealed for the first time that intranasal S100A8 administration to lungs of mice had anti-inflammatory activities, which delayed cancer growth by altering the tumor microenvironment to deplete MDSC and modulate the oxidative balance to encourage accumulation of T cells. This evidence concerns the gene S100A8 and neoplasm.